Browse Drug Recalls
3,458 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 3,458 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 3,458 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Oct 15, 2015 | Screenses Color Sunscreen Tinted facial make-up compact, Broad Spectrum SPF 5... | cGMP Deviations; product does not comply with cGMP requirements | Class II | Sesderma, SL |
| Oct 15, 2015 | Repaskin 30 (octacrylene 4%, oxybenzone 3%, octisalate 3%, octinoxate 3% Avob... | cGMP Deviations; product does not comply with cGMP requirements | Class II | Sesderma, SL |
| Oct 15, 2015 | Dryses Aluminum Chlorohydrate Deodorant for Women, Roll-on, 2.5 fl oz (75 mL)... | cGMP Deviations; product does not comply with cGMP requirements | Class II | Sesderma, SL |
| Sep 25, 2015 | FUROSEMIDE Tablets USP, 20 mg, 1000-count bottle, Rx only, Boehringer Ingelhe... | CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral s... | Class III | Boehringer Ingelheim Roxane Inc |
| Sep 25, 2015 | FUROSEMIDE Tablets USP, 40 mg, 1000-count bottle, Rx only, Boehringer Ingelhe... | CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral s... | Class III | Boehringer Ingelheim Roxane Inc |
| Sep 16, 2015 | UN1002 Air, Compressed, Medical Air, USP, Distributed by Praxair Distribution... | CGMP Deviations: Confirmed customer compliant of odor when turning on a cylinder of medical air. | Class III | Praxair Inc. |
| Sep 16, 2015 | UN1002 Air, Compressed, Breathing Grade, USP, Distributed by Praxair Distribu... | CGMP Deviations: Confirmed customer compliant of odor when turning on a cylinder of medical air. | Class III | Praxair Inc. |
| Jul 29, 2015 | Lisinopril Tablets USP, 5 mg, 1000-count bottles, Rx Only, Manufactured by: W... | CGMP Deviations: An FDA inspection identified inadequate investigations of past market complaints. | Class II | Wockhardt Usa Inc. |
| Jul 29, 2015 | Lisinopril Tablets USP, 20 mg, 1000-count bottles, Rx Only, Manufactured by: ... | CGMP Deviations: An FDA inspection identified inadequate investigations of past market complaints. | Class II | Wockhardt Usa Inc. |
| Jul 10, 2015 | Clonidine Hydrochloride Tablets, USP, 0.1 mg, 100-count bottles, Rx only, Pac... | cGMP Deviations | Class II | PD-Rx Pharmaceuticals, Inc. |
| Jul 9, 2015 | Clonidine Hydrochloride Tablets, USP, 0.3 mg, 100 count HDPE bottles, Rx only... | cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product... | Class II | Mutual Pharmaceutical Company, Inc. |
| Jul 9, 2015 | Clonidine Hydrochloride Tablets, USP, 0.1 mg, packaged in a) 100 count (NDC 5... | cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product... | Class II | Mutual Pharmaceutical Company, Inc. |
| Jul 9, 2015 | Clonidine Hydrochloride Tablets, USP, 0.2 mg, packaged in a) 100 count (NDC 5... | cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product... | Class II | Mutual Pharmaceutical Company, Inc. |
| Jun 5, 2015 | Carb-O-Philic 40 Cream, 40%, a) 3 oz. tube (NDC 54162-640-03) b) 7 oz. tube (... | CGMP Deviation: Poor container closure of the bulk storage container | Class III | Geritrex Corp |
| Jun 1, 2015 | Clarithromycin tablets, USP 500mg, packaged in 10-count blisters (NDC 68084-4... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | American Health Packaging |
| Jun 1, 2015 | Amlodipine besylate tablets, USP 2.5mg, packaged in 10-count blisters (NDC 68... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | American Health Packaging |
| Jun 1, 2015 | Zonisamide capsules, USP 100mg packaged in 10-count blisters (NDC 68084-008-1... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | American Health Packaging |
| Jun 1, 2015 | Azithromycin tablets, USP 500mg, packaged in 10-count blisters (NDC 68084-279... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | American Health Packaging |
| Jun 1, 2015 | Lisinopril tablets, USP 5mg packaged in 10-count blisters (NDC 68084-060-11);... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | American Health Packaging |
| Jun 1, 2015 | Lisinopril tablets, USP 40mg packaged in 10-count blisters (NDC 68084-064-11)... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | American Health Packaging |
| Jun 1, 2015 | Azithromycin tablets, USP 250mg, packaged in 10-count blisters (NDC 68084-278... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | American Health Packaging |
| Jun 1, 2015 | Amlodipine besylate tablets, USP 10 mg, packaged in 10-count blisters (NDC 68... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | American Health Packaging |
| Jun 1, 2015 | Famotidine tablets, USP 20mg, packaged in 10-count blisters (NDC 68084-172-11... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | American Health Packaging |
| Jun 1, 2015 | Lisinopril tablets, USP 20mg packaged in 10-count blisters (NDC 68084-062-11)... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | American Health Packaging |
| Jun 1, 2015 | Amlodipine besylate tablets, USP 5mg, packaged in 10-count blisters (NDC 6808... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | American Health Packaging |
| Jun 1, 2015 | Lisinopril tablets, USP 10mg packaged in 10-count blisters (NDC 68084-061-11)... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | American Health Packaging |
| Jun 1, 2015 | Azithromycin tablets, USP 600mg, packaged in 10-count blisters (NDC 68084-464... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | American Health Packaging |
| May 22, 2015 | Captopril Tablets, USP, 50 mg, 30 Tablets, Rx Only, Dist. By: Wockhardt USA L... | cGMP Deviations; products being recalled in response to a recall notice from the manufacturer, Wo... | Class II | Blenheim Pharmacal, Inc. |
| May 22, 2015 | Clarithromycin Tablets, USP, 500 mg, 20 Tablets, Rx Only, Dist. By: Wockhardt... | cGMP Deviations; products being recalled in response to a recall notice from the manufacturer, Wo... | Class II | Blenheim Pharmacal, Inc. |
| May 12, 2015 | Famotidine Tablets, USP, 20 mg Tablets, Over the Counter, Made in India and l... | CGMP Deviations: Failure of the manufacturer, Wockhardt Ltd, to adequately investigate customer c... | Class II | Allegiant Health |
| Apr 29, 2015 | Azithromycin Tablets, USP, 250 mg, Rx Only, packaged in a) 2 count and b) 4 c... | cGMP Deviations: This recall is a result of the original manufacturer's recall, in which the firm... | Class II | PD-Rx Pharmaceuticals, Inc. |
| Apr 29, 2015 | Azithromycin 500 mg tablets, Rx Only, packaged in a) 1 count, b) 2 count, c) ... | cGMP Deviations: This recall is a result of the original manufacturer's recall, in which the firm... | Class II | PD-Rx Pharmaceuticals, Inc. |
| Apr 22, 2015 | Famotodine Tablets, USP, 20 mg Tablets, Packaged in A) 30 Count Bottles (NDC... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Famotodine Tablets, USP, 20 mg Tablets, For Repacking Only, Packaged in 6500 ... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Clarithromycin Tablets, USP, 500 mg Tablets, 60 Count Bottles, Rx Only. Manuf... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Famotodine Tablets, USP, 40 mg Tablets, Packaged in A) 30 Count Bottles (NDC... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Metoprolol Succinate Extended-Release Tablets, USP, 50 mg Tablets, Packaged i... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Zolpidem Tartrate Tablets, 10 mg Tablets, CIV, Packaged in A) 100 Count Bott... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Lisinopril Tablets USP, 40 mg Tablets, Packaged in A) 100 Count Bottles (NDC:... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Amlodipine Besylate Tablets, 10 mg Tablets, Packaged as A) 90 Count Bottles... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Lisinopril Tablets USP, 20 mg Tablets, Packaged in A) 100 Count Bottles (NDC... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Amlodipine Besylate Tablets, 2.5 mg Tablets, Packaged in 90 Count Bottles, Rx... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Azithromycin Tablets, USP, 500 mg Tablets, Packaged in A) 30 Count Bottles (N... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Extended Phenytoin Sodium Capsules, USP, 100 mg Capsules, Packaged as A) 100 ... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Tamsulosin Hydrochloride Capsules, USP*, 0.4 mg Capsules, Packaged in A) 100 ... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Lamotrigine Extended-Release Tablets, 25 mg Tablets, 30 Count Bottles, Rx Onl... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Azithromycin Tablets, USP, 250 mg Tablets, Packaged in A) 30 Count Bottles (N... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Lisinopril Tablets USP, 2.5 mg Tablets, Packaged in A) 100 Count Bottles (NDC... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Metoprolol Succinate Extended-Release Tablets, USP, 25 mg Tablets, Packaged i... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Metoprolol Succinate Extended-Release Tablets, USP, 200 mg Tablets, Packaged ... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.